Relaxin as novel strategy in the management of atrial fibrillation: potential roles and future perspectives.

Zhao, Zhiqiang; Ng, Chee Yuan; Liu, Tong; Li, Hongmin; Li, Guangping

Zhao, Zhiqiang; Ng, Chee Yuan; Liu, Tong; Li, Hongmin; Li, Guangping.

Afiliação

Zhao Z; Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
Ng CY; Department of Cardiology, Loma Linda University Medical Center, CA, United States.
Liu T; Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
Li H; Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.
Li G; Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China. Electronic address: gp_limail@sina.com.

Int J Cardiol ; 171(3): e72-3, 2014 Feb 15.

Article em En | MEDLINE | ID: mdl-24373631

Assuntos

Fibrilação Atrial/diagnóstico; Fibrilação Atrial/tratamento farmacológico; Relaxina/uso terapêutico; Animais; Gerenciamento Clínico; Previsões; Humanos

Palavras-chave

Atrial fibrillation; Fibrosis; Inflammation; Oxidative stress; Relaxin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Relaxina / Fibrilação Atrial Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google